![Daniel Yadegar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Yadegar
Direktör/Styrelseledamot på
LUMOS PHARMA, INC.
Profil
Daniel Yadegar is the founder of Newpath Management LP, founded in 2018.
Dr. Yadegar currently holds the positions of Director at Lumos Pharma, Inc. and Managing Partner at Double Point Ventures LLC.
Dr. Yadegar completed undergraduate education at Harvard University in 1999 and graduate education at Weill Cornell Medical College in 2004.
Aktiva positioner av Daniel Yadegar
| Företag | Position | Start |
|---|---|---|
| LUMOS PHARMA, INC. | Direktör/Styrelseledamot | - |
Newpath Management LP
 Newpath Management LP Investment ManagersFinance Newpath Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and life sciences sectors. It provides financing for early stage capital requirements. | Grundare | 2018-09-01 |
Daniel Yadegars utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
99
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newpath Management LP
Newpath Management LP Investment ManagersFinance Newpath Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and life sciences sectors. It provides financing for early stage capital requirements. | Finance |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
